Sterling Capital Management LLC Biotechnology

Sterling Capital Management LLC

$7.3 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HUMA Humacyte, Inc.	$341M	$449,000 0.0% of portfolio	89	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$326M	$408,000 0.0% of portfolio	37	Q3 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$298M	$347,000 0.0% of portfolio	41	Q4 2024 Added 5.13%
RVNC Revance Therapeutics, Inc.	$212M	$322,000 0.0% of portfolio	106	Q3 2024 New
YMAB Y M Abs Therapeutics, Inc.	$215M	$298,000 0.0% of portfolio	38	Q3 2024 New
TYRA Tyra Biosciences, Inc.	$468M	$292,000 0.0% of portfolio	21	Q3 2024 New
TSHA Taysha Gene Therapies, Inc.	$83.2M	$285,000 0.0% of portfolio	165	Q3 2024 New
CDXC Chroma Dex Corp.	$539M	$265,000 0.0% of portfolio	50	Q3 2024 New
SANA Sana Biotechnology, Inc.	$430M	$218,000 0.0% of portfolio	134	Q3 2024 New
OCGN Ocugen, Inc.	$119M	$212,000 0.0% of portfolio	263	Q3 2024 New
CADL Candel Therapeutics, Inc.	$254M	$174,000 0.0% of portfolio	20	Q3 2024 New
LRMR Larimar Therapeutics, Inc.	$109M	$166,000 0.0% of portfolio	43	Q3 2024 New
ALEC Alector, Inc.	$107M	$157,000 0.0% of portfolio	83	Q3 2024 New
TNGX Tango Therapeutics, Inc.	$152M	$151,000 0.0% of portfolio	49	Q3 2024 New
XFOR X4 Pharmaceuticals, Inc	$21.3M	$126,000 0.0% of portfolio	172	Q3 2024 New
IGMS Igm Biosciences, Inc.	$36.8M	$110,000 0.0% of portfolio	18	Q3 2024 New
BMEA Biomea Fusion, Inc.	$80M	$109,000 0.0% of portfolio	28	Q3 2024 New
SCPH Sc Pharmaceuticals Inc.	$84.4M	$103,000 0.0% of portfolio	29	Q3 2024 New
SAVA Cassava Sciences Inc	$111M	$99,000 0.0% of portfolio	42	Q3 2024 New
STTK Shattuck Labs, Inc.	$50.4M	$82,000 0.0% of portfolio	68	Q3 2024 New
PEPG Pep Gen Inc.	$44.7M	$76,000 0.0% of portfolio	20	Q3 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$83.2M	$75,000 0.0% of portfolio	150	Q3 2024 New
GLSI Greenwich Life Sciences, Inc.	$148M	$67,000 0.0% of portfolio	6	Q3 2024 New
INMB Inmune Bio, Inc.	$136M	$61,000 0.0% of portfolio	13	Q3 2024 New
OVID Ovid Therapeutics Inc.	$31.7M	$57,000 0.0% of portfolio	61	Q3 2024 New
ALXO Alx Oncology Holdings Inc	$31.4M	$57,000 0.0% of portfolio	34	Q3 2024 New
ELEV Elevation Oncology, Inc.	$6.76M	$55,000 0.0% of portfolio	98	Q3 2024 New
PRLD Prelude Therapeutics Inc	$26.9M	$54,000 0.0% of portfolio	42	Q3 2024 New
GALT Galectin Therapeutics Inc	$93.9M	$49,000 0.0% of portfolio	38	Q3 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$33M	$39,000 0.0% of portfolio	31	Q3 2024 New
AVTE Aerovate Therapeutics, Inc.	$61.6M	$34,000 0.0% of portfolio	13	Q3 2024 New
LYRA Lyra Therapeutics, Inc.	$5.09M	$18,000 0.0% of portfolio	88	Q3 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$13,000 0.0% of portfolio	19	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.